Margin target hit, revenue growth deeply missed 14% guidance
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Paramount integration delivered as promised (330 bps recovery). Growth guidance 'in line with industry' unmet in Q2 (3.9% vs. 14%). No numeric FY27 guidance provided to assess.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Medi Assist delivered on margin recovery (20.4% EBITDA, +331 bps YoY) and PAT grew 167.5%, but Q2 revenue growth of 3.9% significantly misses the prior 14% industry benchmark. Management invokes 3-4 quarter accounting lags and Paramount churn for soft near-term growth; technology scaling and international expansion remain early-stage. Margin target of 22-23% steady-state not yet visible. Hold pending clarity on growth trajectory.
₹241.5 Cr
Revenue · +3.9% YoY₹21.6 Cr
Reported PAT · +167.5% YoYExpanding
Margins · vs guidance: MixedDid the claims hold up?
Core business growth in line with or better than 14% industry
MISSQ2 operating revenue 3.9% YoY, H1 13.8% consolidated — both below 14%
Paramount integration complete Q2 with 330 bps margin improvement
METIntegration complete, 331 bps EBITDA margin expansion achieved YoY
Technology scaling 55% YoY, targeting ~10% of revenue
PartialPlatform ₹19.8 Cr in H1 (4.2% of consolidated), strong growth but still below 10% target
International business expanding, first Thailand contract live
METPlatform live in Southeast Asia, but H1 growth only 1.1% YoY, flat
Retention recovering from Paramount churn, will reach 93-94% in 3-4 quarters
PartialH1 retention at 90.5%, improvement QoQ, but 3-4 quarter lag cited repeatedly
Earnings quality
What changed since the last call
Revenue growth guidance missed
DowngradePrior '14% industry growth or better'; Q2 actual 3.9% YoY operating revenue. H1 13.8% consolidated but much on smaller base post-Paramount carve-out.
Margin recovery confirmed
Upgrade20.4% Q2 EBITDA margin expanded 331 bps YoY; matched '330 bps over 4 quarters' prior claim. Paramount integration boost delivered.
Retention pressure persistent
DowngradeH1 90.5% retention vs. prior 93-94%; Paramount churn and cyber incident cited. Recovery now expected 3-4 quarters out (previously claimed Q2 completion would normalize).
Same-store growth downshifted
DowngradeGroup same-store growth now 7-8% vs. historical 13-14%; market inflation and benefit saturation cited. No near-term recovery expected.
International growth stalled
DowngradeH1 growth only 1.1% YoY despite Thailand platform launch; early-stage, no near-term impact.
The Q&A
Q&A showed analysts pressing hard on weak Q2 TPA growth (1.2% YoY), retention drop-down, and why technology investments haven't improved group retention. Management held firm on 3-4 quarter recovery narrative, accounting timing, and cyber/Paramount churn explanations, but tone was defensive, not confident.
Growth & same-store trajectory — Navid Virani, Bastion Research
PartialGroup business grew 21% in H1, driven by market share gain and pricing. Same-store growth 8%-9% range going forward (down from 13%-14% historical). Expect retention recovery to 93%-94% in 3-4 quarters to boost growth.
TPA growth slowdown — Vikas Sharda, NT Asset Management
PartialAccounting timing — installment premiums recognized over 3-4 quarters; contract liability ₹40-50 Cr revenue equiv. Recognition will catch up in coming quarters. Confident in growth per or faster than market.
Paramount integration & margin normalization — Prithvish Uppal, Nuvama
Partial100% of corporates now on unified platform, full integration, 800+ headcount reduction post-Paramount. Margin steady-state 22%-23% in core business. Q2 at 20.4%; cyber incident in December and migration complexity drove some losses, accounts beginning to come back.
Technology segment scale — Dihraj Kaswan, Incred
AnsweredMost revenue now pure SaaS platform. Contracts kicking in slowly with 5-10x potential per claim vs. current SaaS revenue. Early days but solutions fully independent of TPA offering, available for in-house use by insurers.
Group retention puzzle — Mihir Shah, Meritus
PartialNot every account is viable commercially. Also accounting—some clients not in reporting yet, some left due to pricing/scope, some moved providers. Margin includes overlapping costs of international/tech buildout. Core steady-state 22%-23% achievable once investments monetize and scale.
Guidance
Core business growth in line with or better than industry (~14%)
LowQ2 actual 3.9% YoY; H1 13.8%. India TPA 11.9% YoY in H1 vs. claimed 14% target. Unmet.
Steady-state margin 22%-23% in core business
MediumQ2 at 20.4%, H1 at 20.3%. Management cites overlapping costs from tech/international buildout. Implies margin uplift of 200+ bps still needed.
Risks the call surfaced
Retention & churn
HighH1 retention 90.5% vs. prior 93-94%. Paramount migration churn and cyber incident (Dec post-Paramount) cited. Recovery timeline extended to 3-4 quarters with no guarantee. Group business 70% of revenue.
Growth slowdown
MediumQ2 TPA growth only 1.2% YoY (₹219.6 Cr). Same-store growth declined to 7-8% vs. 13-14% historical due to benefit inflation and IT-ITeS headcount saturation. Industry growing ~14%.
Technology monetization
MediumPlatform revenue only ₹19.8 Cr in H1 (4.2% of consolidated), growth strong but still far from 10% target. Contracts 'kicking in slowly' per management. Revenue potential stated as 5-10x current per-claim rate but unproven.
International expansion
LowInternational revenue ₹20.7 Cr in H1 with only 1.1% growth, flat despite platform live in Southeast Asia. Early-stage, no material near-term contribution.
Accounting timing & visibility
MediumManagement cites 3-4 quarter revenue recognition lag for installment premiums. Contract liability ₹321.7 Cr (vs. ₹280.2 Cr FY26) represents deferred revenue equiv. ₹40-50 Cr per quarter. If realized slower than expected, growth guidance may slippage further.
Management
Score 6/10. Transparent on challenges (Paramount churn, cyber incident, accounting lag) but hedge heavily on forward guidance. Repeatedly cite 3-4 quarter recovery timelines without firm commitments. Candid on margin steady-state (22-23%) vs. current (20.4%). Paramount integration delivered on schedule (330 bps margin recovery achieved). Q2 PAT growth 167.5% strong, but revenue miss 3.9% vs. 14% target. Track record mixed: margin met, growth missed.
1 · Q3-Q4 FY27
Retention recovery begins; management cites 3-4 quarter normalization post-Paramount churn
2 · H2 FY27
Technology platform revenues to accelerate; 4 insurers onboarded this quarter, contracts with 5-10x current claim revenue potential
3 · FY28+
International expansion (Southeast Asia platform live, retail & group membership growing outside India)
Hold pending clarity on growth trajectory.
Informational and educational content only. Not investment advice.